The Prevalence of Anti-HDV in Chronic Hepatitis B Patients

dc.contributor.authorCelen, Mustafa Kemal
dc.contributor.authorGeyik, Mehmet Faruk
dc.contributor.authorUlug, Mehmet
dc.contributor.authorHosoglu, Salih
dc.date.accessioned2024-04-24T17:40:23Z
dc.date.available2024-04-24T17:40:23Z
dc.date.issued2006
dc.departmentDicle Üniversitesien_US
dc.description.abstractIn spite of chronic hepatitis B infection was seen at high ratio in region of Southeast of Anatolia, our data's does not enough about hepatitis delta infection. Because of this reason we investigated the frequency of anti-HDV in chronic active hepatitis B patients. Anti-HDV was looked into 120 patients with chronic active hepatitis B. The relation between anti-HDV positive patients and age, sex, carrying time of HBsAg and positively of HBeAg was evaluated. Positively of anti-HDV was determined in 33/120 (27.5%). The relation between carrying time of HBsAg and positively of anti-HDV was found meaningful statistically (p= 0.001). But the relation between age, sex and positively of HBeAg with positively with anti-HDV was not found meaningful (p> 0.05). Positively of anti-HDV was found at high ratio (27.5%) in chronic hepatitis B patients so that they were evaluated surely about HDV infection.en_US
dc.identifier.endpage29en_US
dc.identifier.issn1307-9441
dc.identifier.issn2147-2939
dc.identifier.issue1en_US
dc.identifier.startpage26en_US
dc.identifier.urihttps://hdl.handle.net/11468/21775
dc.identifier.volume11en_US
dc.identifier.wosWOS:000217140200001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isotren_US
dc.publisherGalenos Yayinciliken_US
dc.relation.ispartofViral Hepatit Dergisi-Viral Hepatitis Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHepatitis Ben_US
dc.subjectHepatitis Deltaen_US
dc.subjectEpidemiologyen_US
dc.subjectRisk Factorsen_US
dc.titleThe Prevalence of Anti-HDV in Chronic Hepatitis B Patientsen_US
dc.titleThe Prevalence of Anti-HDV in Chronic Hepatitis B Patients
dc.typeArticleen_US

Dosyalar